These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8308312)

  • 1. Pattern of D-xylose excretion test in kala-azar patients.
    Hati AK; Bhattacharyya J; Mukherjee H; Ghosh S; Das DC
    J Indian Med Assoc; 1993 Oct; 91(10):267. PubMed ID: 8308312
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil.
    Lima Verde FA; Lima Verde FA; Lima Verde IA; Silva Junior GB; Daher EF; Lima Verde EM
    J Nephrol; 2007; 20(4):430-6. PubMed ID: 17879209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kala-azar (visceral Leishmaniasis) from Khotang.
    Joshi S; Bajracharya BL; Baral MR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):232-4. PubMed ID: 18603904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of 17-ketosteroids in Kala-azar.
    CHATTERJI A; SEN GUPTA PC
    J Indian Med Assoc; 1958 Jul; 31(1):11-3. PubMed ID: 13575837
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal.
    Rijal S; Boelaert M; Regmi S; Karki BM; Jacquet D; Singh R; Chance ML; Chappuis F; Hommel M; Desjeux P; Van der Stuyft P; Le Ray D; Koirala S
    Trop Med Int Health; 2004 Jun; 9(6):724-9. PubMed ID: 15189464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
    Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
    Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.
    Bern C; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Amann J; Wahed MA; Wagatsuma Y; Breiman RF; Williamson J; Secor WE; Maguire JH
    Am J Trop Med Hyg; 2007 May; 76(5):909-14. PubMed ID: 17488915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of visceral leishmaniasis in India.
    Bora D
    Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-kala-azar dermal leishmaniasis and visceral leishmaniasis in a child--or is it para-kala-azar dermal leishmaniasis?
    Mendiratta V; Chander R
    Int J Dermatol; 2009 Sep; 48(9):1027-8. PubMed ID: 19703001
    [No Abstract]   [Full Text] [Related]  

  • 10. Kala-azar in Uttar Pradesh--a study of 66 patients.
    Mittal V; Singh VK; Ichhpujani RL
    J Commun Dis; 2002 Mar; 34(1):43-9. PubMed ID: 12718341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Test of urinary excretion of xylose: use and limitations in the separation of normal children and tropical sprue patients].
    Santiago Borrero PJ; Santini R; Ramírez I; Maldonado N
    Bol Asoc Med P R; 1972 Dec; 64(12):319-22. PubMed ID: 4522009
    [No Abstract]   [Full Text] [Related]  

  • 12. Sero-epidemiological study of kala-azar in a village of Varanasi district, India.
    Kumar R; Pai K; Kumar P; Pandey HP; Sundar S
    Trop Med Int Health; 2006 Jan; 11(1):41-8. PubMed ID: 16398754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [D-xylose test in healthy children].
    Klinowska W; Idasiak K
    Pol Tyg Lek; 1975 Dec; 30(49):2041-3. PubMed ID: 1197089
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the D-xylose absorption test: measurement in blood and urine].
    Lemoyne M; Poitras P; Bannon P
    Union Med Can; 1984 Feb; 113(2):138-41. PubMed ID: 6710705
    [No Abstract]   [Full Text] [Related]  

  • 15. Post kala azar dermal leishmaniasis in Sudan.
    Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
    East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological study of kala-azar by direct agglutination test in two rural communities of eastern Nepal.
    Koirala S; Karki P; Das ML; Parija SC; Karki BM
    Trop Med Int Health; 2004 Apr; 9(4):533-7. PubMed ID: 15078273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [D-xylose test in the evaluation of intestinal absorption in healthy infants and children under 3].
    Zareba J; Laskowski J; Sliwa F
    Pol Tyg Lek; 1966 Sep; 21(37):1399-400. PubMed ID: 5975977
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study of blood xylose curves and urinary excretion with oral doses based on body weight].
    Martín Ruiz JL; Figueruela López B; Peña Angulo JF
    Rev Esp Enferm Apar Dig; 1985 Oct; 68(4):337-41. PubMed ID: 4081257
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.
    Berman JD; Badaro R; Thakur CP; Wasunna KM; Behbehani K; Davidson R; Kuzoe F; Pang L; Weerasuriya K; Bryceson AD
    Bull World Health Organ; 1998; 76(1):25-32. PubMed ID: 9615494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.